SCHEMBL468253

SCHEMBL468253

CCCc1csc(C(Cc2ccc(NS(=O)(=O)O)cc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)OC)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL679276 1.00 PTPRB (1.00) PTPRB
SCHEMBL679275 1.00 PTPRB (1.00) PTPRB
SCHEMBL468317 0.93 PTPRB (1.00) PTPRB
SCHEMBL680192 0.93 PTPRB (1.00) PTPRB
SCHEMBL16061190 0.93 PTPRB (0.87) PTPRB
Ammonia Solution, Strong SCHEMBL16030961 0.93 PTPRB (0.98) PTPRB
SCHEMBL13638112 0.92 PTPRB (0.87) PTPRB
SCHEMBL680122 0.91 PTPRB (1.00) PTPRB
SCHEMBL680123 0.91 PTPRB (1.00) PTPRB
SCHEMBL678593 0.91 PTPRB (1.00) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385763-A1 METHODS FOR TREATING VASCULAR LEAK SYNDROME Akebia Therapeutics Inc. (US) 2011-11-16 EP claimed
US-20110253725-A1 MULTI-PORT BEVERAGE AND FOOD CONTAINERS KILLIAN WILLIAM 2011-10-20 US claimed
WO-2010081172-A1 METHODS FOR TREATING VASCULAR LEAK SYNDROME AKEBIA THERAPEUTICS INC. (US) 2010-07-15 WO claimed